Cargando…

Prevalence of celiac disease in Iranian patients with rheumatologic disorders

AIM: Patients with Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Fibromyalgia (FM) may have underlying non-diagnosed celiac disease (CD). BACKGROUND: The aim of this study was to determine the prevalence of CD in patients with these underlying diseases in Iran. METHODS: This cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhami, Elham, Zakeri, Zahra, Sadeghi, Amir, Rostami-Nejad, Mohammad, Volta, Umberto, Zali, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040036/
https://www.ncbi.nlm.nih.gov/pubmed/30013748
_version_ 1783338785447084032
author Elhami, Elham
Zakeri, Zahra
Sadeghi, Amir
Rostami-Nejad, Mohammad
Volta, Umberto
Zali, Mohammad Reza
author_facet Elhami, Elham
Zakeri, Zahra
Sadeghi, Amir
Rostami-Nejad, Mohammad
Volta, Umberto
Zali, Mohammad Reza
author_sort Elhami, Elham
collection PubMed
description AIM: Patients with Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Fibromyalgia (FM) may have underlying non-diagnosed celiac disease (CD). BACKGROUND: The aim of this study was to determine the prevalence of CD in patients with these underlying diseases in Iran. METHODS: This cross-sectional study was performed among 300 consecutive patients with SLE, RA, and FM (each group 100 patients) since 2015 to 2017. The blood samples were collected and serum IgA anti-tissue trans-glutaminase (Anti-tTG) level was assessed for all patients. The seropositive patients underwent endoscopy and duodenal/jejunal biopsy according to the Marsh classification. RESULTS: Out of 300 investigated patients with mean age of 41.2 years old, 92% of patients with SLE, RA and fibromyalgia were women. Among 100 patients with SLE, only 1 subject (1%), out of 100 patients with RA 3 subjects (3%), and none of the patients with fibromyalgia were seropositive for CD (with overall prevalence 1.4). All four patients were female and categorized as Marsh III. CONCLUSION: The results of the study indicated that patients with lupus have the same prevalence, but subjects with RA had three times higher prevalence rate than normal population for CD. Therefore, CD investigation in these individuals can improve their quality of life.
format Online
Article
Text
id pubmed-6040036
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-60400362018-07-16 Prevalence of celiac disease in Iranian patients with rheumatologic disorders Elhami, Elham Zakeri, Zahra Sadeghi, Amir Rostami-Nejad, Mohammad Volta, Umberto Zali, Mohammad Reza Gastroenterol Hepatol Bed Bench Original Article AIM: Patients with Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Fibromyalgia (FM) may have underlying non-diagnosed celiac disease (CD). BACKGROUND: The aim of this study was to determine the prevalence of CD in patients with these underlying diseases in Iran. METHODS: This cross-sectional study was performed among 300 consecutive patients with SLE, RA, and FM (each group 100 patients) since 2015 to 2017. The blood samples were collected and serum IgA anti-tissue trans-glutaminase (Anti-tTG) level was assessed for all patients. The seropositive patients underwent endoscopy and duodenal/jejunal biopsy according to the Marsh classification. RESULTS: Out of 300 investigated patients with mean age of 41.2 years old, 92% of patients with SLE, RA and fibromyalgia were women. Among 100 patients with SLE, only 1 subject (1%), out of 100 patients with RA 3 subjects (3%), and none of the patients with fibromyalgia were seropositive for CD (with overall prevalence 1.4). All four patients were female and categorized as Marsh III. CONCLUSION: The results of the study indicated that patients with lupus have the same prevalence, but subjects with RA had three times higher prevalence rate than normal population for CD. Therefore, CD investigation in these individuals can improve their quality of life. Shaheed Beheshti University of Medical Sciences 2018 /pmc/articles/PMC6040036/ /pubmed/30013748 Text en ©2018 RIGLD, Research Institute for Gastroenterology and Liver Diseases This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Elhami, Elham
Zakeri, Zahra
Sadeghi, Amir
Rostami-Nejad, Mohammad
Volta, Umberto
Zali, Mohammad Reza
Prevalence of celiac disease in Iranian patients with rheumatologic disorders
title Prevalence of celiac disease in Iranian patients with rheumatologic disorders
title_full Prevalence of celiac disease in Iranian patients with rheumatologic disorders
title_fullStr Prevalence of celiac disease in Iranian patients with rheumatologic disorders
title_full_unstemmed Prevalence of celiac disease in Iranian patients with rheumatologic disorders
title_short Prevalence of celiac disease in Iranian patients with rheumatologic disorders
title_sort prevalence of celiac disease in iranian patients with rheumatologic disorders
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040036/
https://www.ncbi.nlm.nih.gov/pubmed/30013748
work_keys_str_mv AT elhamielham prevalenceofceliacdiseaseiniranianpatientswithrheumatologicdisorders
AT zakerizahra prevalenceofceliacdiseaseiniranianpatientswithrheumatologicdisorders
AT sadeghiamir prevalenceofceliacdiseaseiniranianpatientswithrheumatologicdisorders
AT rostaminejadmohammad prevalenceofceliacdiseaseiniranianpatientswithrheumatologicdisorders
AT voltaumberto prevalenceofceliacdiseaseiniranianpatientswithrheumatologicdisorders
AT zalimohammadreza prevalenceofceliacdiseaseiniranianpatientswithrheumatologicdisorders